Adaptive to provide clonoSEQ MRD test for Amgen drug development

Amgen will use Adaptive’s MRD assay in several drug development programmes under its haematology portfolio. Credit: Narupon Promvichai from Pixabay.



  • Adaptive to provide clonoSEQ MRD test to Amgen